Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Duffy

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Trials|July 16, 2017
Twin-Twin Transfusion Syndrome: study protocol for developing, disseminating, and implementing a core outcome setAsma Khalil, Helen Perry, James Duffy, et al.
Bioanalysis|November 26, 2016
LC-MS/MS strategies for therapeutic antibodies and investigation into the quantitative impact of antidrug-antibodiesMatthew Ewles, Ranbir Mannu, Chris Fox, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 15, 2022
Effect of the COVID-19 Pandemic on Otolaryngology Trainee Surgical Case Numbers: A Multi-institutional ReviewScott Mann, James Duffy, Tyler Muffly, et al.
Plos One|September 27, 2018
Popular interest in vertebrates does not reflect extinction risk and is associated with bias in conservation investmentThomas Davies, Andrew Cowley, Jon Bennie, et al.
The American Journal of Cardiology|September 17, 2011
Long-term predictors of mortality after percutaneous coronary intervention in the era of drug-eluting stentsWilliam McLeish Wilson, Nick Andrianopoulos, David Clark, et al.
Trials|February 24, 2021
Study protocol: a core outcome set for perinatal interventions for congenital diaphragmatic herniaSimen Vergote, Felix De Bie, Jan Bosteels, et al.
Journal of Cheminformatics|June 3, 2024
Protein target similarity is positive predictor of in vitro antipathogenic activity: a drug repurposing strategy for Plasmodium falciparumReagan M Mogire, Silviane A Miruka, Dennis W Juma, et al.
Antimicrobial Agents and Chemotherapy|October 31, 2022
Dephospho-Coenzyme A Kinase Is an Exploitable Drug Target against Plasmodium falciparum: Identification of Selective Inhibitors by High-Throughput Screening of a Large Chemical Compound LibraryArif Nurkanto, Riyo Imamura, Yulia Rahmawati, et al.
Antimicrobial Agents and Chemotherapy|August 28, 2024
Dose-fractionation studies of a <i>Plasmodium</i> phosphatidylinositol 4-kinase inhibitor in a humanized mouse model of malariaLiezl Gibhard, Mathew Njoroge, Mwila Mulubwa, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Escaping from Flatland: Antimalarial Activity of sp<sup>3</sup>-Rich Bridged Pyrrolidine DerivativesBrian Cox, James Duffy, Victor Zdorichenko, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Trials|July 16, 2017
Twin-Twin Transfusion Syndrome: study protocol for developing, disseminating, and implementing a core outcome setAsma Khalil, Helen Perry, James Duffy, et al.
Bioanalysis|November 26, 2016
LC-MS/MS strategies for therapeutic antibodies and investigation into the quantitative impact of antidrug-antibodiesMatthew Ewles, Ranbir Mannu, Chris Fox, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 15, 2022
Effect of the COVID-19 Pandemic on Otolaryngology Trainee Surgical Case Numbers: A Multi-institutional ReviewScott Mann, James Duffy, Tyler Muffly, et al.
Plos One|September 27, 2018
Popular interest in vertebrates does not reflect extinction risk and is associated with bias in conservation investmentThomas Davies, Andrew Cowley, Jon Bennie, et al.
The American Journal of Cardiology|September 17, 2011
Long-term predictors of mortality after percutaneous coronary intervention in the era of drug-eluting stentsWilliam McLeish Wilson, Nick Andrianopoulos, David Clark, et al.
Trials|February 24, 2021
Study protocol: a core outcome set for perinatal interventions for congenital diaphragmatic herniaSimen Vergote, Felix De Bie, Jan Bosteels, et al.
Journal of Cheminformatics|June 3, 2024
Protein target similarity is positive predictor of in vitro antipathogenic activity: a drug repurposing strategy for Plasmodium falciparumReagan M Mogire, Silviane A Miruka, Dennis W Juma, et al.
Antimicrobial Agents and Chemotherapy|October 31, 2022
Dephospho-Coenzyme A Kinase Is an Exploitable Drug Target against Plasmodium falciparum: Identification of Selective Inhibitors by High-Throughput Screening of a Large Chemical Compound LibraryArif Nurkanto, Riyo Imamura, Yulia Rahmawati, et al.
Antimicrobial Agents and Chemotherapy|August 28, 2024
Dose-fractionation studies of a <i>Plasmodium</i> phosphatidylinositol 4-kinase inhibitor in a humanized mouse model of malariaLiezl Gibhard, Mathew Njoroge, Mwila Mulubwa, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Escaping from Flatland: Antimalarial Activity of sp<sup>3</sup>-Rich Bridged Pyrrolidine DerivativesBrian Cox, James Duffy, Victor Zdorichenko, et al.
Pageof 7